Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersCOX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.Synthesis, docking and biological activities of novel hybrids celecoxib and anthraquinone analogs as potent cytotoxic agents.Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferationAntitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo.Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).Synergistic effect of gefitinib and rofecoxib in mesothelioma cells.Nimesulide inhibited the growth of hypopharyngeal carcinoma cells via suppressing Survivin expression.Role of Cyclooxygenase-2 on Intermittent Hypoxia-Induced Lung Tumor Malignancy in a Mouse Model of Sleep Apnea.Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomasCelecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.
P2860
Q26739665-022C0E6E-25E4-4384-AF3B-B114D79EC1AAQ34784887-51F55E9B-D97A-4704-B794-F020A3CD94C7Q34834711-9D2E47A0-7D0D-4045-9F92-5CDDAFC40DEAQ35879417-433BD557-B893-4E62-81D1-18A37C8D1756Q36571885-681520C8-3550-49BB-AA74-B0C9BCEA2F1FQ36594073-D292C6E6-49FD-45D9-BAAC-43FDBA9782BDQ38794246-16B28975-E11D-459F-9A5F-A6B8DEB90B03Q39292338-2BC70E18-C9CB-4CCC-9ED7-3D071469ADDDQ39373081-4642A70A-08F5-47FE-B925-550A50555BB0Q40289814-24C92978-DD7C-463C-A287-9FFFE8BC6066Q40449390-6ECF4C77-ACB1-406D-9B19-2F70A51D910FQ53275350-D1AD0E1D-7594-4037-897A-E272D96C9FC2
P2860
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@en
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@nl
type
label
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@en
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@nl
prefLabel
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@en
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@nl
P2093
P2860
P356
P1476
Antitumor enhancement of celec ...... a expressing Cyclooxygenase-2.
@en
P2093
Hongryull Pyo
Jae Ho Han
Young Taek Oh
P2860
P2888
P356
10.1186/1756-9966-27-66
P577
2008-11-11T00:00:00Z
P5875
P6179
1022398681